Astria Therapeutics
ATXS
ATXS
33 hedge funds and large institutions have $41.7M invested in Astria Therapeutics in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
Holders
33
Holding in Top 10
–
Calls
$3.54M
Puts
$1.45M
Top Buyers
| 1 | +$2.38M | |
| 2 | +$144K | |
| 3 | +$129K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$124K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$87.8K |
Top Sellers
| 1 | -$1.7M | |
| 2 | -$185K | |
| 3 | -$89.6K | |
| 4 |
OWP
Old Well Partners
Charlotte,
North Carolina
|
-$65K |
| 5 |
Wolverine Trading
Chicago,
Illinois
|
-$65K |